[144] Bicycle Therapeutics plc American SEC Filing

Rhea-AI Filing Summary

Triumph Financial, Inc. (TFIN) – Form 4 insider filing

Director Laura Easley reported the July 1, 2025 receipt of 653 fully-vested common shares granted under the company’s 2014 Omnibus Incentive Plan. The award was recorded at $0 cost, indicating a standard equity compensation grant rather than an open-market purchase. Following the transaction, Easley’s direct holdings rose to 8,301 shares. She also reports 1,895 shares held indirectly as trustee of the Easley Family Trust, for total beneficial ownership of 10,196 shares.

No derivative securities were involved, and there were no dispositions. This filing reflects routine board-level compensation and represents a modest increase in insider ownership (approximately 0.04% of TFIN’s 25 million share count, assuming prior public float). While not financially material to the company, insider accumulation can be viewed as a modestly positive governance signal.

Positive

• Director increased direct ownership by 653 shares, signaling continued alignment with shareholders.
• No insider sales reported, avoiding negative perception of insider confidence.

Negative

• None.

Insights

Equity Research Analyst

TL;DR: Routine director grant; negligible dilution; mildly positive insider-confidence signal.

The 653-share grant to Director Easley is standard board compensation, costing the company de minimis dilution. Post-transaction ownership of ~10k shares keeps her economic alignment intact. The absence of sales and continued indirect trust holdings suggest no bearish sentiment from this insider. From a valuation standpoint, the event is immaterial but directionally supportive.

Corporate Governance Specialist

TL;DR: Grant aligns director incentives; no red flags detected.

The use of fully-vested shares under the 2014 Omnibus Plan is consistent with prevailing governance practices, promoting director-stock alignment without option overhang complexity. No 10b5-1 plan usage was indicated, and the trustee disclosure for the family trust meets transparency standards. Overall governance impact is neutral to slightly positive.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	2266	16066.00	47761845	07/02/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/02/2025	Restricted Stock Units	Issuer			2266	07/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alistair Milnes Blocks A & B Portway Building Cambridge X0 CB21 6GS	Common Stock	04/03/2025	1038	7767.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Triumph Financial (TFIN) shares did Director Laura Easley acquire?

She received 653 fully-vested common shares on July 1, 2025.

What was the purchase price of the shares acquired by the director?

The shares were granted at $0 cost as part of the 2014 Omnibus Incentive Plan.

What is Laura Easley’s total Triumph Financial ownership after the transaction?

She directly owns 8,301 shares and indirectly controls 1,895 shares, totaling 10,196 shares.

Did the Form 4 report any dispositions or sales by the director?

No. The filing only lists an equity grant; there were no sales or disposals.

Are any derivative securities reported in this Form 4?

No derivative securities were acquired or disposed; only common stock was involved.